BIOTON S.A. (WSE:BIO)
Poland · Delayed Price · Currency is PLN 4.300
+0.010 (0.23%)
Oct 24, 2025, 5:00 PM CET
BIOTON Company Description
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles.
BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
BIOTON S.A.
| Country | Poland |
| Founded | 1989 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 364 |
| CEO | Jeremy Launders |
Contact Details
Address: ul. Poznanska 12 Ozarów Mazowiecki, 05-850 Poland | |
| Phone | 48 22 721 4000 |
| Website | bioton.pl |
Stock Details
| Ticker Symbol | BIO |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLBIOTN00029 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Mateusz Patryk Kosecki | Head of Biolek Business Unit and Chief Executive Officer of Biolek Sp. Z O.O. |
| Artur Mroz-Goncalves | Chief Executive Officer and Sales and Marketing Director at Bioton Marketing Agency (BMA) |
| Jeremy Launders | Chief Executive Officer and President of the Management Board |
| Anna Grabowska | Senior Finance Manager |
| Michal Deptuch | Operations Director |
| Romuald Apollo Harwas | Member of Management Board |
| Renata Prokopczyk | Chief Accountant |
| Dariusz Gurtowski | Director of Science and Technology |
| Kamila Musnicka | Director of Legal Department |
| Ewelina Romanska | Director of Human Resources and Communication |